NSNikolai Stenfors

Nikolai Stenfors

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nikolai Stenfors has a total of 161 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exhaled particle size and phospholipid composition of the respiratory tract lining fluid following moderate-intensity exercise in sub-zero conditions

    by Helen Hanstock, Angelos Gavrielatos, Iluta Ratkevica, Per Larsson, Anna-Carin Olin, Nikolai Stenfors

    Exercise-induced bronchoconstriction (EIB) commonly develops following prolonged exercise in cold, dry environments, but the acute mechanisms underlying airway responses to such environmental stressors remain poorly understood. Exhaled particle analysis offers a novel, non-invasive approach to assess respiratory tract lining fluid (RTLF) composition and may provide mechanistic insights into early airway responses before clinically detectable changes occur. This study investigated exhaled particle characteristics and lipid composition in response to moderate-intensity exercise in sub-zero conditions among healthy atopic and non-atopic individuals. Eighteen recreationally active participants (14 male) aged 29 ± 6 years, performed two moderate-intensity exercise trials (30 and 90 min duration) in a climate chamber set to -15°C. Participants provided exhaled particle (PEx) samples using the PExA® method, before and 30 min after each exercise trial. The PExA® device analysed particle mass and count across eight size bins (0.4 – 5 µm) and the collected PEx samples underwent lipidomic analysis to assess differences in the RTLF composition before and after exercise. Exercise induced a significant increase in smaller particles in PEx samples (0.4-0.7m; p < 0.01). Three lipid species were altered after the 30-min exercise trial, and 11 after 90-min exercise. Phosphatidylethanolamine PE(16:1_18:0) was the only lipid that consistently increased across both exercise durations (30 min: p = 0.023; 90 min: p = 0.044; g = 0.97). No significant differences in overall particle characteristics were observed between atopic and non-atopic participants, though three specific lipid species showed differential exercise responses between groups, including an oxidised phosphatidylcholine species PC(16:0_9:0;O) (p = 0.006, q = 0.59, g = 0.86). These results provide preliminary insight into airway surfactant responses to exercise in a cold climate and contribute to the growing understanding of how the PExA® method can be applied as a non-invasive tool for respiratory health assessment in an acute setting.

  • Open Access

    Ten-year incidence, remission, and relapse of asthma among Swedish elite endurance athletes

    by Modar Alhamdan, Anne Lindberg, Nikolai Stenfors

    Background Asthma is highly prevalent among elite endurance athletes, but long-term natural history data beyond 5 years are lacking. Understanding disease trajectory and sport-specific risks are important for clinical management. Methods We conducted a 10-year prospective postal survey of Swedish elite endurance athletes in biathlon, cross-country skiing, ski orienteering, and orienteering. Baseline questionnaires were collected 2011–2015, with follow-up 10 years later. We calculated 10-year cumulative incidence of physician-diagnosed asthma, remission (no medication use during last 12 months at follow-up), and relapse (medication use at follow-up after none at baseline). Factors associated with incident asthma were analyzed using logistic regression. Results Of 591 eligible athletes, 290 (49.1%) responded at 10-year follow-up. Among 220 athletes without baseline asthma, 50 developed asthma (cumulative incidence 22.7%, 95% CI 17.7–28.7%). Among 45 athletes with asthma and asthma medication use at baseline, 19 achieved remission (42.2%, 95% CI 29.0-56.7%). Among 16 athletes with physician-diagnosed asthma but no medication at baseline, 3 relapsed (18.8%, 95% CI 6.6–43.0%). Cross-country skiers had more than twice the cumulative incidence (30.2%) compared to orienteers (13.2%). Multivariate logistic regression adjusting for age, sex, training volume, allergic rhinitis, and family history did not identify statistically significant independent associations. Conclusions One in four elite endurance athletes developed asthma over 10 years, with cross-country skiers showing more than twice the cumulative incidence of orienteers, while over 40% with active asthma achieved remission. No statistically significant factors associated with incident asthma were identified. Asthma remains a dynamic condition throughout athletic careers and warrants continuing reassessment.

  • Open Access

    Severity of adult-onset asthma - a matter of blood neutrophils and severe obesity

    by Sofia Winsa-Lindmark, Caroline Stridsman, Axel Sahlin, Linnea Hedman, Nikolai Stenfors, Tomi Myrberg, Anne Lindberg, Eva Rönmark, Helena Backman


  • Open Access

    Elite skiers' experiences of heat‐ and moisture‐exchanging devices and training and competition in the cold: A qualitative survey

    by Mats Jong, Helen G. Hanstock, Nikolai Stenfors, Mats Ainegren

    Background and Aims: Winter endurance athletes have a high prevalence of exercise‐induced bronchoconstriction (EIB) and asthma, probably due to repeated and prolonged inhalation of cold and dry air. Heat‐ and moisture‐exchanging devices (HME) warm and humidify inhaled air and prevent EIB. The aim of this study was to share cross‐country skiers and biathletes' experiences of training and competition in low temperatures, views on temperature limits, usage of HME, and consequences of cold exposure on their health.Methods: Eleven Swedish World Championship or Olympic medalists in cross‐country skiing and biathlon were interviewed and transcripts were analyzed using qualitative content analysis.Results: Participants described how cold temperatures predominantly affected the airways, face, and extremities. During training, extreme cold was managed by choosing warmer clothing, modification of planned sessions, use of HME, delaying training, or changing location. In competition, participants described limited possibility for such choices and would prefer adjustment of existing rules (i.e., more conservative temperature limits), especially since they understood elite skiing in low temperatures to present an occupational hazard to their health. Participants had at times used HMEs during training in cold environments but described mixed motives for their use—that HMEs warm and humidify cold inhaled air but introduce additional resistance to breathing and can cause problems due to mucus and ice build‐up. Skiers also perceived that they had become more sensitive to cold during the latter part of their careers.Conclusions: The present study gives a unique insight into the “cold” reality of being an elite athlete in skiing and biathlon. Cold exposure results in negative health consequences that are preventable, which means that rules must be followed, and organizers should acknowledge responsibility in protecting athletes from occupational hazards. Development of evidence‐based guidelines for protection of athletes' respiratory health should be a focus for future translational research.


  • Open Access

    High prevalence of interstitial lung abnormalities in middle-aged never-smokers

    by Ida Pesonen, Fredrik Johansson, Åse Johnsson, Anders Blomberg, Marianne Boijsen, John Brandberg, Kerstin Cederlund, Arne Egesten, Össur Ingi Emilsson, Jan E. Engvall, et al.

    Background: Interstitial lung abnormalities (ILA) are incidental findings on chest computed tomography (CT). These patterns can present at an early stage of fibrotic lung disease. Our aim was to estimate the prevalence of ILA in the Swedish population, in particular in never-smokers, and find out its association with demographics, comorbidities and symptoms.Methods: Participants were recruited to the Swedish CArdioPulmonary BioImage Study (SCAPIS), a population-based survey including men and women aged 50–64 years performed at six university hospitals in Sweden. CT scan, spirometry and questionnaires were performed. ILA were defined as cysts, ground-glass opacities, reticular abnormality, bronchiectasis and honeycombing.Findings: Out of 29 521 participants, 14 487 were never-smokers and 14 380 were men. In the whole population, 2870 (9.7%) had ILA of which 134 (0.5%) were fibrotic. In never-smokers, the prevalence was 7.9% of which 0.3% were fibrotic. In the whole population, age, smoking history, chronic bronchitis, cancer, coronary artery calcium score and high-sensitive C-reactive protein were associated with ILA. Both ILA and fibrotic ILA were associated with restrictive spirometric pattern and impaired diffusing capacity of the lung for carbon monoxide. However, individuals with ILA did not report more symptoms compared with individuals without ILA.Interpretation: ILA are common in a middle-aged Swedish population including never-smokers. ILA may be at risk of being underdiagnosed among never-smokers since they are not a target for screening.


  • Open Access

    A longitudinal follow-up of continuous laryngoscopy during exercise test scores in athletes irrespective of laryngeal obstruction, respiratory symptoms, and intervention

    by Tommie Irewall, Catharina Bäcklund, Estelle Naumburg, Marie Ryding, Nikolai Stenfors

    Background: Exercise-induced laryngeal obstruction (EILO) is diagnosed by the continuous laryngoscopy during exercise (CLE) test. Whether or how much CLE test scores vary over time is unknown. This study aimed to compare CLE test scores in athletes over time, irrespective of respiratory symptoms and grade of laryngeal obstruction. Methods: Ninety-eight athletes previously screened for EILO were invited for a follow-up CLE test irrespective of CLE scores and respiratory symptoms. Twenty-nine athletes aged 16–27 did a follow-up CLE test 3–23 months after the baseline test. Laryngeal obstruction at the glottic and supraglottic levels was graded by the observer during exercise, at baseline and follow-up, using a visual grade score (0–3 points). Results: At baseline, 11 (38%) of the 29 athletes had moderate laryngeal obstruction and received advice on breathing technique; among them, 8 (73%) reported exercise-induced dyspnea during the last 12 months. At follow-up, 8 (73%) of the athletes receiving advice on breathing technique had an unchanged supraglottic score. Three (17%) of the 18 athletes with no or mild laryngeal obstruction at baseline had moderate supraglottic obstruction at follow-up, and none of the 3 reported exercise-induced dyspnea. Conclusions: In athletes with repeated testing, CLE scores remain mostly stable over 3–24 months even with advice on breathing technique to those with EILO. However, there is some intraindividual variability in CLE scores over time. Trial registration: ISRCTN, ISRCTN60543467, 2020/08/23, retrospectively registered, ISRCTN – ISRCTN60543467: Investigating conditions causing breathlessness in athletes.


  • Open Access

    A longitudinal follow-up of continuous laryngoscopy during exercise test scores in athletes

    by Tommie Irewall, Catharina Bäcklund, Estelle Naumburg, Marie Ryding, Nikolai Stenfors

    Background Exercise-induced laryngeal obstruction (EILO) is diagnosed by the continuous laryngoscopy during exercise (CLE). Whether or how much CLE test scores vary over time is unknown. This study aimed to compare CLE test scores in athletes over time, irrespective of respiratory symptoms and grade of laryngeal obstruction. Methods Ninety-eight athletes previously screened for EILO were invited for a follow-up CLE irrespective of CLE scores and respiratory symptoms. Twenty-nine athletes aged 16–27 did a follow-up CLE 3–23 months after the baseline test. Laryngeal obstruction at the glottic and supraglottic levels was graded by the observer during exercise, at baseline and follow-up, using a visual grade score (0–3 points). Results At baseline, 11 (38%) of the 29 athletes had moderate laryngeal obstruction and received advice on breathing technique; among them, 8 (73%) reported exercise-induced dyspnea during the last 12 months. At follow-up, 8 (73%) of the athletes receiving advice on breathing technique had an unchanged supraglottic score. Three (17%) of the 18 athletes with no or mild laryngeal obstruction at baseline had moderate supraglottic obstruction at follow-up, and none of the 3 reported exercise-induced dyspnea. Conclusions In athletes with repeated testing, CLE scores remain mostly stable over 3–24 months even with advice on breathing technique to those with EILO. However, there is some intraindividual variability in CLE scores over time. Trial Registration ISRCTN, ISRCTN60543467, 2020/08/23, retrospectively registered, ISRCTN - ISRCTN60543467: Investigating conditions causing breathlessness in athletes

  • Open Access

    Adjusted incidence, remission, and relapse of self‐reported physician‐diagnosed asthma and asthma medication usage in endurance athletes

    by Nikolai Stenfors, Tommie Irewall, Anne Lindberg

    Longitudinal studies are needed to increase our knowledge of the natural history of asthma in athletes. Our aims were to estimate the incidence, remission, and relapse, of self-reported asthma among endurance athletes. A postal questionnaire on self-reported physician-diagnosed asthma, asthma medication, allergy, and respiratory symptoms was sent annually 2011-2015 to 666 Swedish elite athletes competing in cross-country skiing, biathlon, ski orienteering, or orienteering. Athletes at risk for (1) incident asthma were those without previous self-reported asthma, use of asthma medication, or asthma-like symptoms, (2) remission those who discontinued asthma medication usage and (3) relapse those who resumed asthma medication usage during the observation period. The population at risk was used as denominator in the calculations of subsequent event rate. At baseline, 89% responded, the median age was 17 years and 47% were females. Of the 373 athletes with never asthma nor use of asthma medication/asthma-like symptoms at baseline, 31 (8%) reported physician-diagnosed asthma during follow-up, giving an adjusted incidence rate of asthma of 42/1000 person years. Among the 110 athletes with self-reported asthma and use of asthma medication at baseline, 26 (24%) discontinued use of asthma medication during the follow-up, giving a remission rate of 142/1000 person years. Of the 31 athletes with previous asthma and no use of asthma medication at baseline, 9 (29%) resumed use of asthma medication during follow-up, giving a relapse rate was 148/1000 person years. Elite endurance athletes have a high incidence of self-reported physician-diagnosed asthma. The remission and relapse of self-reported asthma medication usage in endurance athletes appear similar to that of the general population.


  • Cause-Specific Death in Chronic Airway Obstruction and Restrictive Spirometric Pattern

    by Helena Backman, Sami Sawalha, Ulf Nilsson, Linnea Hedman, Caroline Stridsman, Lowie E. G. W. Vanfleteren, Bright I. Nwaru, Nikolai Stenfors, Eva Rönmark, Anne Lindberg